address1,address2,city,zip,country,phone,fax,website,industry,industryKey,industryDisp,sector,sectorKey,sectorDisp,longBusinessSummary,companyOfficers,compensationAsOfEpochDate,executiveTeam,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,dividendRate,dividendYield,exDividendDate,payoutRatio,fiveYearAvgDividendYield,beta,trailingPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,tradeable,enterpriseValue,forwardPE,profitMargins,floatShares,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,impliedSharesOutstanding,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,earningsQuarterlyGrowth,netIncomeToCommon,trailingEps,lastSplitFactor,lastSplitDate,enterpriseToRevenue,enterpriseToEbitda,52WeekChange,SandP52WeekChange,lastDividendValue,lastDividendDate,quoteType,currentPrice,targetHighPrice,targetLowPrice,targetMeanPrice,targetMedianPrice,recommendationMean,recommendationKey,numberOfAnalystOpinions,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,debtToEquity,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,earningsGrowth,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,symbol,language,region,typeDisp,quoteSourceName,triggerable,customPriceAlertConfidence,longName,regularMarketChangePercent,regularMarketPrice,marketState,regularMarketChange,regularMarketDayRange,fullExchangeName,averageDailyVolume3Month,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekChangePercent,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,earningsCallTimestampStart,earningsCallTimestampEnd,isEarningsDateEstimate,epsTrailingTwelveMonths,epsCurrentYear,priceEpsCurrentYear,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,sourceInterval,exchangeDataDelayedBy,averageAnalystRating,cryptoTradeable,corporateActions,regularMarketTime,shortName,exchange,messageBoardId,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,market,esgPopulated,hasPrePostMarketData,firstTradeDateMilliseconds,trailingPegRatio
Cnergy IT Park,"Unit A2, 3rd floor, Unit A, 8th floor Appa Saheb Marathe Marg Prabhadevi",Mumbai,400025,India,91 22 2439 5200,91 22 2431 5331,https://www.jbpharma.com,Drug Manufacturers - Specialty & Generic,drug-manufacturers-specialty-generic,Drug Manufacturers - Specialty & Generic,Healthcare,healthcare,Healthcare,"J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dosage forms, such as tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, cold rubs, eye drops, troches, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners; and contract manufacturing services. The company provides its products in gastroenterology, anti-infectives, wound care, neonatology and pediatrics, gynaecology, dental, vitamins and minerals, hypertension, diabetes, nephrology, respiratory, pain-analgesic, dermatology, antivirals, lozenges, and contrast media and radio diagnostic therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Mumbai, India.","[{'maxAge': 1, 'name': 'Mr. Nikhil Ashokkumar Chopra', 'age': 51, 'title': 'CEO & Whole-Time Director', 'yearBorn': 1973, 'fiscalYear': 2024, 'totalPay': 71338000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Suresh  Amin', 'title': 'Assistant Vice President \x96 Human Resource', 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Narayan  Saraf', 'age': 44, 'title': 'Chief Financial Officer', 'yearBorn': 1980, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Kunal  Khanna', 'age': 44, 'title': 'President of Operations', 'yearBorn': 1980, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Bhagwat Singh Deora', 'age': 42, 'title': 'Vice President of Finance & Accounts', 'yearBorn': 1982, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Suresh  Bhise', 'age': 58, 'title': 'Vice President of Information & Technology', 'yearBorn': 1966, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Sridhar  Bharadwaj', 'age': 57, 'title': 'Vice President of HR & Administration', 'yearBorn': 1967, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Himanshu  Ranvah', 'age': 39, 'title': 'Vice President of Legal', 'yearBorn': 1985, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Pradeep Kumar Singh', 'age': 60, 'title': 'President of Global Business', 'yearBorn': 1964, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Parmeshwar B. Bang', 'age': 56, 'title': 'Executive Vice President of Operations of Daman', 'yearBorn': 1968, 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}]",1735603200,[],86400,2,1671.7,1671.7,1663.3,1800.0,1671.7,1671.7,1663.3,1800.0,17.0,1.02,1738886400,0.16239999,0.85,-0.089,42.57987,613407,613407,360444,140588,140588,0.0,0.0,0,0,276630208512,1385.75,2030.0,7.0605135,1643.304,1727.7015,15.5,0.009271999,INR,False,256016269312,29.29284,0.16835,80468821,156059008,0.48193002,0.28136998,156516992,220.577,8.036196,1743379200,1774915200,1743379200,0.155,6595800064,41.63,2:1,1694995200,6.534,24.812,-0.04735583,0.094471335,8.5,1738886400,EQUITY,1772.6,2457.0,1595.0,2048.7693,2038.0,1.30769,strong_buy,13,4465600000,28.69,10318399488,278900000,1.996,3.041,39179898880,0.812,252.158,0.13014,0.20752001,26014400512,6407915520,9024499712,0.137,0.102,0.66397005,0.26336,0.18958001,INR,JBCHEPHARM.NS,en-US,US,Equity,Delayed Quote,True,HIGH,J. B. Chemicals & Pharmaceuticals Limited,6.0357733,1772.6,POSTPOST,100.900024,1663.3 - 1800.0,NSE,360444,386.84998,0.27916288,1385.75 - 2030.0,-257.40002,-0.12679805,-4.7355833,1747220340,1754477940,1754913600,1747297800,1747297800,True,41.63,51.43077,34.465748,129.29602,0.07868053,44.898438,0.025987381,15,15,1.3 - Strong Buy,False,[],1750413601,J B CHEMICALS AND PHARMA,NSI,finmb_878634,Asia/Kolkata,IST,19800000,in_market,False,False,1025495100000,
